435 related articles for article (PubMed ID: 20846680)
21. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
22. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
23. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
[TBL] [Abstract][Full Text] [Related]
25. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
[TBL] [Abstract][Full Text] [Related]
26. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
[TBL] [Abstract][Full Text] [Related]
27. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
28. Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.
Krabbe LM; Bagrodia A; Haddad AQ; Kapur P; Khalil D; Hynan LS; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
J Urol; 2015 May; 193(5):1486-93. PubMed ID: 25451830
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience.
Gill IS; Sung GT; Hobart MG; Savage SJ; Meraney AM; Schweizer DK; Klein EA; Novick AC
J Urol; 2000 Nov; 164(5):1513-22. PubMed ID: 11025694
[TBL] [Abstract][Full Text] [Related]
30. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
[TBL] [Abstract][Full Text] [Related]
31. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
Hagiwara M; Kikuchi E; Tanaka N; Matsumoto K; Ide H; Miyajima A; Masuda T; Nakamura S; Oya M
J Urol; 2013 Jun; 189(6):2062-8. PubMed ID: 23328579
[TBL] [Abstract][Full Text] [Related]
32. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
Rouprêt M; Hupertan V; Seisen T; Colin P; Xylinas E; Yates DR; Fajkovic H; Lotan Y; Raman JD; Zigeuner R; Remzi M; Bolenz C; Novara G; Kassouf W; Ouzzane A; Rozet F; Cussenot O; Martinez-Salamanca JI; Fritsche HM; Walton TJ; Wood CG; Bensalah K; Karakiewicz PI; Montorsi F; Margulis V; Shariat SF; ;
J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
[TBL] [Abstract][Full Text] [Related]
34. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
Margulis V; Youssef RF; Karakiewicz PI; Lotan Y; Wood CG; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Shariat SF;
J Urol; 2010 Aug; 184(2):453-8. PubMed ID: 20620397
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
[TBL] [Abstract][Full Text] [Related]
36. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL
Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011
[TBL] [Abstract][Full Text] [Related]
37. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.
Bolenz C; Fernández MI; Trojan L; Herrmann E; Becker A; Weiss C; Alken P; Ströbel P; Michel MS
Urology; 2008 Aug; 72(2):364-9. PubMed ID: 18579189
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.
Gadzinski AJ; Roberts WW; Faerber GJ; Wolf JS
J Urol; 2010 Jun; 183(6):2148-53. PubMed ID: 20399468
[TBL] [Abstract][Full Text] [Related]
39. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
[TBL] [Abstract][Full Text] [Related]
40. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
